Clinical Edge Journal Scan

Clinical Edge Journal Scan

Neoadjuvant ET: A reasonable standard-of-care in stage II/III ER+ BC

Publish date: February 24, 2023

Read More

Clinical Edge Journal Scan

Neoadjuvant chemotherapy with nab-paclitaxel+pembrolizumab shows encouraging pCR rates in TNBC

Publish date: February 24, 2023

Read More

Clinical Edge Journal Scan

Postoperative accelerated partial breast irradiation noninferior to whole breast irradiation in early BC

Publish date: February 24, 2023

Read More

Clinical Edge Journal Scan

Commentary: HER2+-targeted therapy, ovarian suppression, and adjuvant therapy in breast cancer, February 2023

Author:: Erin Roesch, MD

Publish date: January 27, 2023

Read More

Clinical Edge Journal Scan

BC with metabolic abnormalities: No benefit of adding metformin to neoadjuvant chemotherapy

Publish date: January 26, 2023

Read More

Clinical Edge Journal Scan

Microcalcifications and high breast density increase risk for breast cancer

Publish date: January 26, 2023

Read More

Clinical Edge Journal Scan

Breast cancer: Nipple-sparing mastectomy after neoadjuvant chemotherapy is oncologically safe

Publish date: January 26, 2023

Read More

Clinical Edge Journal Scan

HER2+ metastatic BC: Meta-analysis demonstrates superior efficacy of pyrotinib over lapatinib

Publish date: January 26, 2023

Read More

Clinical Edge Journal Scan

Improved survival with systemic treatment+local ablative therapy in oligometastatic BC

Publish date: January 26, 2023

Read More

Clinical Edge Journal Scan

HER2 expression has no impact on prognosis in metastatic TNBC

Publish date: January 26, 2023

Read More

Clinical Edge Journal Scan

HER2+ BC: Adding pyrotinib to neoadjuvant trastuzumab+docetaxel shows promise in phase 3 study

Publish date: January 26, 2023

Read More

Pages